Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Budesonid, ATC A07EA06 für die Zeit 01.03.2026 - 29.02.2028 (zzgl. Verlängerungsoption 1x12 Monate)
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Budesonid, ATC A07EA06 für die Zeit 01.03.2026…”. Bids close on 5 January 2029.
The work
Non-exclusive discount agreement for the active substance Budesonid, ATC A07EA06, for the period 01.03.2026 to 29.02.2028 (plus one 12-month extension option).
- Agreement is a framework contract for all interested pharmaceutical companies on the same conditions
- Contract ends automatically with the entry into force of an exclusive contract for the same active substance
Key facts
- Contract period
- 01.03.2026 to 29.02.2028 (plus one 12-month extension option)
- Evaluation
- Selection criteria are 'Siehe Antragsschreiben' (see application letter).
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- § 130a Absatz 8 SGB V
- Regularien des 4. Teils des GWB
- Zulassungsmodells
- offene Verfahren
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Angebotsschreibenelectronic submission per email
- Anerkennung der vertraglichen Maßgaben der DAK-Gesundheitsigned contract with name or company stamp
- Anlage 1 zum Vertragfilled out and submitted per email
- Anlage 2 zum VertragExcel file with active ingredients to be included in the contract
- Angebotelectronic submission per email